Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Brain : a Journal of Neurology
|
June 19, 2019
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Massimo Filippi, Paolo Preziosa, Brenda L Banwell, et al.
Human Brain Mapping
|
November 27, 2008
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study
Maria A Rocca, Martina Absinta, Paola Valsasina, et al.
Alzheimer'S Research & Therapy
|
May 14, 2016
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
Rik Vandenberghe, Juha O Rinne, Mercè Boada, et al.
Brain : a Journal of Neurology
|
March 23, 2021
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy
Christoph Mahler, Adrian-Minh Schumacher, Marcus Unterrainer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 28, 2022
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study
Maria A Rocca, Paola Valsasina, Alessandro Meani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 26, 2013
Brain atrophy and lesion load predict long term disability in multiple sclerosis
Veronica Popescu, Federica Agosta, Hanneke E Hulst, et al.
Neurology
|
December 12, 2024
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis
Neus Mongay-Ochoa, Deborah Pareto, Manel Alberich, et al.
Therapeutic Advances in Neurological Disorders
|
August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Der Nervenarzt
|
July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]
Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Human Molecular Genetics
|
November 18, 2008
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Sergio E Baranzini, Joanne Wang, Rachel A Gibson, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Brain : a Journal of Neurology
|
June 19, 2019
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Massimo Filippi, Paolo Preziosa, Brenda L Banwell, et al.
Human Brain Mapping
|
November 27, 2008
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study
Maria A Rocca, Martina Absinta, Paola Valsasina, et al.
Alzheimer'S Research & Therapy
|
May 14, 2016
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
Rik Vandenberghe, Juha O Rinne, Mercè Boada, et al.
Brain : a Journal of Neurology
|
March 23, 2021
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy
Christoph Mahler, Adrian-Minh Schumacher, Marcus Unterrainer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 28, 2022
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study
Maria A Rocca, Paola Valsasina, Alessandro Meani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 26, 2013
Brain atrophy and lesion load predict long term disability in multiple sclerosis
Veronica Popescu, Federica Agosta, Hanneke E Hulst, et al.
Neurology
|
December 12, 2024
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis
Neus Mongay-Ochoa, Deborah Pareto, Manel Alberich, et al.
Therapeutic Advances in Neurological Disorders
|
August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Der Nervenarzt
|
July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]
Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Human Molecular Genetics
|
November 18, 2008
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Sergio E Baranzini, Joanne Wang, Rachel A Gibson, et al.
Page
of 14